I relish the opportunity to work with companies operating in a range of different sectors and investment banks on high profile and innovative capital markets transactions.
ckeastbutler@cooley.com
Claire Keast-Butler’s practice focuses on capital markets transactions. She represents issuers, investment banks and investors on initial public offerings and secondary offerings. She also regularly advises listed companies on corporate and securities law matters and corporate governance, and has considerable experience in public and private mergers and acquisitions and general corporate matters.
Download full bio
Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction
Silence Therapeutics – $56.5 Million Registered Direct Offering
Biote Agrees to Combine With SPAC Haymaker Acquisition Corp. III
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Rent the Runway – $357 Million IPO
View all
Capital Markets
Public Companies
Mergers & Acquisitions
Life Sciences
Aviation – Manned & Unmanned
Claire was fantastic to work with. Not only is she extremely knowledgeable in capital markets transactions, she is also affable, easy to talk to and responsive.
University College LondonLLB, Bachelors of LawHonors, 1998
England & Wales
Top 10 Considerations for Management in a Continental European IPO January 31, 2023
Amryt Pharma to Sell to Chiesi Farmaceutici in $1.48 Billion Cross-Border Transaction January 9, 2023
PEG Releases New Statement of Principles for the Disapplication of Pre-Emption Rights November 17, 2022
UK Legal 500 - Leading Individual - Equity Capital Markets (2023)
+44 20 7556 4211
Locations